Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kura Oncology

6.31
+0.13002.10%
Post-market: 6.310.00000.00%17:44 EDT
Volume:1.01M
Turnover:6.36M
Market Cap:509.56M
PE:-3.12
High:6.41
Open:6.27
Low:6.15
Close:6.18
Loading ...

Kura Oncology’s Promising Clinical Advances and Strategic Pipeline Developments Justify Buy Rating

TIPRANKS
·
11 Dec 2024

Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)

TIPRANKS
·
10 Dec 2024

Promising Clinical Trial Developments in Kura Oncology’s Ziftomenib for AML Treatment

TIPRANKS
·
10 Dec 2024

Jefferies Reaffirms Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
09 Dec 2024

Kura Oncology, Kyowa Kirin report data on KOMET-007 at ASH meeting

TIPRANKS
·
09 Dec 2024

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

GlobeNewswire
·
09 Dec 2024

Kura Oncology holds a pharmaceutical update conference call

TIPRANKS
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)

TIPRANKS
·
08 Dec 2024

Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Cooper Co (COO) and Ironwood Pharma (IRWD)

TIPRANKS
·
06 Dec 2024

Kura Oncology management to meet with Cantor Fitzgerald

TIPRANKS
·
05 Dec 2024

Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

Insider Monkey
·
05 Dec 2024

Kura Oncology to Host Virtual Investor Event on December 9, 2024

GlobeNewswire
·
02 Dec 2024

Stifel Nicolaus Keeps Their Hold Rating on Kura Oncology (KURA)

TIPRANKS
·
26 Nov 2024

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

GlobeNewswire
·
25 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Bruker (BRKR)

TIPRANKS
·
25 Nov 2024

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds

Insider Monkey
·
23 Nov 2024

BofA lowers Kura Oncology price target to $29, sees buying opportunity

TIPRANKS
·
22 Nov 2024

Kura Oncology Inc : Bofa Global Research Cuts Price Objective to $29 From $36

THOMSON REUTERS
·
22 Nov 2024

Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings

Benzinga
·
22 Nov 2024

Analysts supportive of Kura/Kirin deal despite major selloff in shares

seekingalpha
·
22 Nov 2024